Attovia Therapeutics (ATTO) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 15 51 sessions, August 5, 2026 to October 15, 2026
- Largest daily move
- +14.4% close of August 17, 2026
- 1-month change
- -37.6% closing prices, September 15, 2026 to October 15, 2026
Company Description
Attovia Therapeutics (NASDAQ: ATTO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $677.5M.
ATTO has declined 37.6% over the past month. The last closing price was $14.78.
This page collects what Stock Titan holds for ATTO, including price data, latest news, SEC filings, insider trading activity, upcoming events, and short interest trends.
Stock Performance
Attovia Therapeutics (ATTO) closed at $14.78 on October 15, 2026. Over the past month, the price has lost 37.6%.
ATTO Metrics & Rankings
Price returns through October 15, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Attovia Therapeutics has 5 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences, earnings, IPO, offering. View all ATTO news →
SEC Filings
Attovia Therapeutics has filed 10 recent SEC filings, including 4 Form 4/A, 2 Form 3/A, 1 Form 4, 1 Form 144. The most recent filing was submitted on October 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ATTO SEC filings →
Insider Radar
Insider buying activity at Attovia Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Phase 2 trial starts
Phase 1 starts
Attovia Therapeutics has 2 upcoming scheduled events. The next event, "Phase 2 trial starts", is scheduled for January 1, 2027 (in 76 days). Investors can track these dates to stay informed about potential catalysts that may affect the ATTO stock price.
Short Interest History
Short interest in Attovia Therapeutics (ATTO) currently stands at 1.6 million shares, up 98.5% from the previous reporting period, representing 6.5% of the float. Since August 2026, short interest has increased by 222.3%.
Days to Cover History
Days to cover for Attovia Therapeutics (ATTO) currently stands at 3.0 days, down 25.7% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has increased by 198%. Across the settlements charted above, it has ranged from 1.0 to 4.0 days.
ATTO Company Profile & Sector Positioning
Attovia Therapeutics (ATTO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.